Neonates: birth to <28 days; infants: 28 days to ≤3 months; toddlers: >3 months to ≤2 years; children: >2 years to ≤11 years; adolescents: >11 to ≤17 years
Neonates: birth to <28 days; infants: 28 days to ≤3 months; toddlers: >3 months to ≤2 years; children: >2 years to ≤11 years; adolescents: >11 to ≤17 years |
| Figure 3: Time (minutes) from end of administration of rocuronium to onset of neuromuscular blockade (NMB) (per-protocol group). |
